RCM
PMVP icon

RA Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

RA Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,710,265
Closed -$20.4M – 76
2022
Q3 		$20.4M Hold
1,710,265
– – 0.43% 50
2022
Q2 		$24.4M Hold
1,710,265
– – 0.65% 42
2022
Q1 		$35.6M Hold
1,710,265
– – 0.78% 40
2021
Q4 		$39.5M Hold
1,710,265
– – 0.7% 43
2021
Q3 		$51M Hold
1,710,265
– – 0.71% 39
2021
Q2 		$58.4M Hold
1,710,265
– – 0.94% 31
2021
Q1 		$56.3M Hold
1,710,265
– – 0.85% 36
2020
Q4 		$105M Hold
1,710,265
– – 1.47% 20
2020
Q3 		$60.7M Buy
+1,710,265
New +$62.9M 1.11% 29

Other funds holding PMVP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

RA Capital Management's PMVP Position: Q4 2022 in Review

RA Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2022, closing a stake of 1,710,265 shares — an estimated $20.4M sold.

RA Capital Management first reported a position in PMVP in Q3 2020 and held it in 9 quarters. The position peaked at $105M in Q4 2020. 114 funds tracked by Wall St. Rank hold PMVP as of Q4 2022.

  • RA Capital Management reported no remaining PMV Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • RA Capital Management sold 1,710,265 PMV Pharmaceuticals shares in Q4 2022, an estimated $20.4M.
  • RA Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • RA Capital Management's PMV Pharmaceuticals position peaked at $105M in Q4 2020.
  • 114 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.